// App-Quantinova.ai

150 : SGLT2 inhibition in heart failure with a reduced ejection fraction: how many patients would benefit?

Researchers

Presenter

  • Jacquelyn Hooper

Principal Investigators

  • Steven Shaw

  • Paul Callan

  • Simon Williams

Medical Centers

  • Wythenshawe Hospital, Manchester, Manchester, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Congestive heart failure

  • Type 2 diabetes mellitus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved